Invest now
Laurus Labs share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹1,970.35(1.77%)September 11, 2026 15:53:03 PM IST
- NSE
- BSE
- Vol : 2.34 M (NSE + BSE)Last 20 day avg : 3.64 M
Laurus Labs is trading 1.77% upper at Rs 1,970.35 as compared to its last closing price. Laurus Labs has been trading in the price range of 1,981.45 & 1,917.10. Laurus Labs has given 75.54% in this year & 4.09% in the last 5 days. Laurus Labs has TTM P/E ratio 74.91 as compared to the sector P/E of 37.04.There are 12 analysts who have initiated coverage on Laurus Labs. There are 2 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.The company posted a net profit of 367.60 Crores in its last quarter.Listed peers of Laurus Labs include Sun Pharmaceutical Industries (-1.18%), Divi's Laboratories (-0.84%), Torrent Pharmaceuticals (0.95%).The Mutual Fund holding in Laurus Labs was at 10.15% in 30 Jun 2026. The MF holding has decreased from the last quarter. The FII holding in Laurus Labs was at 28.00% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 12 Sep 2026, 05:11 AM IST
- BetaMedium volatility0.98Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.48The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.10Annual dividends as a percentage of the stock price.
- P/BHigher than historical values19.81The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values96.17Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation24.37The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Laurus Labs News
Laurus Labs Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,842.00 | -1.18 | 4,41,947.09 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,326.00 | -0.84 | 2,47,576.00 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,975.00 | 0.95 | 1,89,233.01 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,365.00 | -1.09 | 1,10,272.68 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,119.50 | 0.13 | 1,11,670.56 | 21.19 | 4.24 | 0.09 | 14.22 |
Mutual Fund Ownership
View allLaurus Labs Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-24 | Quarterly Results |
| 2026-04-30 | Audited Results & Interim Dividend |
| 2026-01-23 | Quarterly Results |
| 2025-10-23 | Quarterly Results & Interim Dividend |
| 2025-07-25 | Quarterly Results |
About the company Laurus Labs
- IndustryBiotechnology & Drugs
- ISININE947Q01028
- BSE Code540222
- NSE CodeLAURUSLABS
Laurus Labs Limited is an India-based company. The Company is a pharmaceutical manufacturing organization. It is engaged in developing and manufacturing active pharmaceutical ingredients (APIs) and intermediates. It supplies anti-retroviral APIs and intermediates. It provides contract and custom manufacturing solutions, allowing client organizations to outsource various stages of the manufacturing process. It is also engaged in development and manufacturing of animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements catering to the needs of stem cells and regenerative medicine, vaccines and biological drugs, cultured meat, and cell-culture media manufacturing. It offers precision fermentation as a contract development and manufacturing organization (CDMO) service. Its service is offered to protein companies and bio-manufacturers operating across healthcare, food, nutrition, personal care, and bio-based materials markets.
Laurus Labs Share Price FAQs
Laurus Labs is trading at 1970.35 as on Fri Sep 11 2026 10:23:03. This is 1.77% upper as compared to its previous closing price of 1936.00.
The market capitalization of Laurus Labs is 106460.42 Cr as on Fri Sep 11 2026 10:23:03.
The average broker rating on Laurus Labs is Hold. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 3 analysts have given a buy rating
- 3 analysts have given a hold rating
- 3 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Laurus Labs is 1981.00 whereas the 52 wk low is 822.85
Laurus Labs can be analyzed on the following key metrics -
- TTM P/E: 74.91
- Sector P/E: 37.04
- Dividend Yield: 0.10%
- D/E ratio: -
Laurus Labs reported a net profit of 888.79 Cr in 2026.
The Mutual Fund Shareholding was 10.15% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Laurus Labs QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.